Reduction of complement factor H binding to CLL cells improves the induction of rituximab-mediated complement-dependent cytotoxicity.

Authors :: Hörl, S
Bánki, Z
Huber, G
Ejaz, A
Windisch, D
Muellauer, B
Willenbacher, E
Steurer, M
Stoiber, H
Source :: Leukemia (08876924). Nov2013, Vol. 27 Issue 11, p2268-2268. 1p.
Publication Year :: 2013
Abstract: A correction to the article "Reduction of complement factor H binding to CLL cells improves the induction of rituximab-mediated complement-dependent cytotoxicity" by D. Windisch and B. Muellauer that was published in the previous issue.

Full Text Access

Tools